Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Non-cash Items (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Non-cash Items data on record, last reported at $10.9 million in Q4 2025.

  • For Q4 2025, Non-cash Items fell 73.89% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $10.9 million, down 73.89%, while the annual FY2025 figure was $10.9 million, 4.97% down from the prior year.
  • Non-cash Items reached $10.9 million in Q4 2025 per OCUL's latest filing, down from $41.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $41.6 million in Q4 2024 and bottomed at $7000.0 in Q4 2022.
  • Average Non-cash Items over 5 years is $13.8 million, with a median of $10.9 million recorded in 2025.
  • Peak YoY movement for Non-cash Items: crashed 99.95% in 2022, then surged 47957.14% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $13.3 million in 2021, then plummeted by 99.95% to $7000.0 in 2022, then soared by 47957.14% to $3.4 million in 2023, then surged by 1135.73% to $41.6 million in 2024, then crashed by 73.89% to $10.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $10.9 million in Q4 2025, $41.6 million in Q4 2024, and $3.4 million in Q4 2023.